Qinghai Spring Medicinal Resources Technology Co., Ltd.
600381.SS · SHH
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CN¥2 | CN¥5 | CN¥7 | CN¥5 |
| - Cash | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| + Debt | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Enterprise Value | CN¥2 | CN¥4 | CN¥7 | CN¥5 |
| Revenue | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Growth | 26.4% | 33.5% | 25.4% | – |
| Gross Profit | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 27.2% | 60.4% | 46.1% | 19.7% |
| EBITDA | -CN¥0 | -CN¥0 | -CN¥0 | -CN¥0 |
| % Margin | -63.2% | -108.4% | -104.3% | -140% |
| Net Income | -CN¥0 | -CN¥0 | -CN¥0 | -CN¥0 |
| % Margin | -73.5% | -125.2% | -179.5% | -194.6% |
| EPS Diluted | -0.34 | -0.46 | -0.49 | -0.42 |
| % Growth | 26.1% | 6.1% | -16.7% | – |
| Operating Cash Flow | CN¥0 | CN¥0 | -CN¥0 | -CN¥0 |
| Capital Expenditures | -CN¥0 | -CN¥0 | -CN¥0 | -CN¥0 |
| Free Cash Flow | CN¥0 | CN¥0 | -CN¥0 | -CN¥0 |